Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Festive Nostalgia Leaves No Scone Unturned

Melbourne, Australia. 20 No., 2018 /Medianet International-AsiaNet/ -- Chestnuts roasting on an open fire and fresh pumpkin pie are synonymous with cherished childhood memories of the Festiv...

5G+, By All for All

GUANGZHOU, China, Oct. 23, 2020 /PRNewswire-Asianet/ -- -Guangzhou will witness the 2020 World 5G Convention on November 26This article was written by the World 5G Convention Organizing Comm...

CTA1000 CCB (Asia) Hong Kong Open 2025 Over 150 China’s Tennis Elites Set to Ignite Victoria Park in November

HONG KONG SAR - Media OutReach Newswire - 27 October 2025 - The China Tennis Tour CCB (Asia) Hong Kong Open 2025 (hereafter "CTA1000 CCB (Asia) Hong Kong Open") will return to Victoria Park...

SKYWORTH continues to support athletes in ASEAN by sponsoring ...

MANILA, Philippines, Dec. 12, 2019 /PRNewswire-AsiaNet/ -- The 30th Southeast Asian Games finally drew to a close in the Philippines thanks to the commendable efforts by all the participatin...

Huawei's New FusionServer 2298 V5 in the Spotlight at ISP Summit

SHENZHEN, China, April 1, 2019 /PRNewswire-AsiaNet/ -- At the Huawei ISP Summit Asia Pacific 2019, Huawei showcased a rich package of intelligent computing products, including the brand new ...

Servier Completes the Acquisition of Symphogen

PARIS, June 4, 2020 /PRNewswire-AsiaNet/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S.Symphogen wil...

The Untold Story Releases Meng Guanglu's Documentary on His Pe...

TIANJIN, China, July 24, 2021, /PRNewswire-AsiaNet/-- The Untold Story is a documentary studio focusing on personal stories of the Chinese living in China. In the third episode, it tells sto...

Alliance Ventures Invests in the Mobility House to Boost Elect...

PARIS and MUNICH, June 27, 2019 /PRNewswire-AsiaNet/ -- Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, announces an investment in The Mobility House, a te...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastStreamEastjojobetcialis 20 mg fiyat